ArticleCureus2026

Real-World Feasibility of Fibrosis-4-Based Fibrosis Risk Stratification in Patients With Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Daniza A Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.